Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. DermConsult

Post-Hoc Analysis of Scalp Psoriasis Treatment After Five Years

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    Scalp psoriasis can be a particularly challenging manifestation for many patients. So recently, a post-hoc analysis of data looking at ixekizumab for moderate to severe plaque psoriasis in adult patients with five years of treatment was conducted. Read more on the details of the study and what this means for psoriasis patients.

Recommended
Details
Comments
  • Overview

    Scalp psoriasis can be a particularly challenging manifestation for many patients. So recently, a post-hoc analysis of data looking at ixekizumab for moderate to severe plaque psoriasis in adult patients with five years of treatment was conducted. Read more on the details of the study and what this means for psoriasis patients.

Schedule10 Oct 2024